business
Roche Expands Liver Treatment Portfolio with $3.5B Acquisition
Basel-based Roche acquires California's 89bio for $3.5 billion, strengthening its position in liver and cardiovascular disorder treatments.
12 months ago · 1 source
healthcare
Roche CEO Proposes Direct Drug Sales to Cut US Prices
Swiss pharmaceutical giant Roche suggests eliminating intermediaries could halve US drug prices, marking significant shift in international healthcare pricing strategy.
SWI swissinfo.ch
business
Record-Breaking Compensation Package for Novartis CEO Sparks Controversy
Ethos Foundation recommends shareholders vote against Novartis executive compensation after CEO's salary reaches unprecedented CHF19.2 million.
SWI swissinfo.ch
